The effect of medroxyprogesterone acetate and clomiphene citrate on platelet function in menopausal women

Maturitas

Volumn 24, Issue 1-2, 1996, Pages 51-56

  Tepper, Ron ^a   Bar, Jacob ^b   Goldberger, Shmuel ^a   Fuchs, Jacob ^b   Beyth, Yoram ^c   Ovadia, Jardena ^b  

^a MEIR MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

HRT; Menopause; Platelet function

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENALIN; ANTIESTROGEN; CLOMIFENE CITRATE; CONJUGATED ESTROGEN; IKALCOMIN; MEDROXYPROGESTERONE ACETATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MENOPAUSE; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION;

EID: 0029992128     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(95)01001-7     Document Type: Article

References (24)

1. Ross R, Glomset JA. The pathogenesis of atherosclerosis; part I. N Engl J Med 1976; 295: 369-377.
2. Farbeszewski R, Kurowska T. Platelet adhesiveness, aggregation and fibrinolysis after the oral administration of the contraceptive "Lyndiol". Throm Diath Haemorrh 1970; 24: 304-307.
3. Dugoalc M, Masi AT. Hormonal contraception and thromboembolic disease: effects of oral contraceptives on hemostatic mechanisms. A review of the literature. J Chronic Dis 1971; 23: 775-790.
4. Astedt B. Coagulation and fibrinolytic studies on 17 β-estradiol and synthetic estrogen. Acta Obstet Gynecol Scand (Suppl) 1977; 65: 45-48.
5. Shevde N, Sussman II, Rosner F, Pacholuk V. Oral contraceptives and platelet aggregation. Am J Obstet Gynecol 1978; 132: 303-306.
6. Manchester JH, Herman MV, Gorlin R. Premenopausal castration and documented coronary atherosclerosis. Am J Cardiol 1971; 28: 33-37.
7. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease: the Framingham study. Ann Intern Med 1978; 98: 157-161.
8. Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol 1981; 139: 47-51.
9. Colditz GA, Willet WC, Stampher MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary-heart disease in women. N Engl J Med 1987; 316: 1105-1110.
10. Stampfer MJ, Colditz GA, Willet WC. Menopause and heart disease. A review. Ann NY Acad Sci 1990; 592: 193-203.
11. Stampfer MJ, Colditz GA, Willet WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: 10 year follow-up from the nurses' health study. N Engl J Med 1991; 325: 756-762.
12. Tepper R, Goldberger S, May J, Luz J, Beyth Y. Hormonal replacement therapy in postmenopausal women and cardiovascular disease: an overview. Obstet Gynecol Surv 1992; 47(6): 426-431.
13. Henderson BE, Paganini-Hill A, Ross RK. Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol 1988; 159: 312-317.
14. Paganini-Hill A, Ross RK, Henderson BE. Post-menopausal oestrogen treatment and stroke. A prospective study. Br Med J 1988; 297: 519-522.
15. Hirvonen E, Malkonen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981; 304: 560-563.
16. Kokko E, Janne O, Kauppila A, Vihko R. Cyclic clomiphene citrate treatment lowers cytosol estrogen, progestin receptor concentrations in the endometrium of postmenopausal women on estrogen replacement therapy. J Clin Endocrinol Metal 1981; 52: 345-349.
17. Kauppila A, Janne O, Kivinen S, Kokko E, Lantto T, Tuimala R, Vihko R. Postmenopausal hormone replacement therapy with estrogen periodically supplemented with antiestrogen. Am J Obstet Gynecol 1981; 140: 787-792.
18. DeLuca MJ, McElroy WD. Kinetics of firefly luciferase catalyzed reactions. Biochemistry 1974; 13: 921-925.
19. Feinman RD, Lubowsky J, Charo I, Zabinski MP. The lumi-aggregometer: a new instrument for simultaneous measurement of secretion and aggregation by platelets. J Lab Clin Med 1977; 90: 125-129.
20. Elwood PC, Sweetnam PM. Aspirin and secondary mortality after myocardial infarction. Lancet 1979; ii: 1313-1315.
21. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran LM, Tyroler HA, Rifkind BM. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program follow-up study. Circulation 1987; 75: 1102-1109.
22. Stampfer MJ, Sacks FM, Salvini S, Willet MW, Hennekens CH. A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarctions. N Engl J Med 1991b; 325: 373-381.
23. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-1204.
24. Bar Y, Tepper R, Fuchs M, Pardo J, Ovadia J. The effect of replacement therapy on platelet aggregation and ATP release in postmenopausal women. Obstet Gynecol 1993; 81: 261-264.